Randomized Phase 2 Study on the Relationship Between Circulating VEGF and Weekly or Every-Four-Week Zometa [zoledronic acid] in Breast Cancer Patients With Bone Metastases.
Phase of Trial: Phase II/III
Latest Information Update: 16 Oct 2015
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Advanced breast cancer; Breast cancer; Cancer metastases
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 12 Oct 2009 Status changed from active, no longer recruiting to completed.
- 12 Oct 2009 Results have been presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History